Answers are grounded in this paper and cite their sources.
Adjuvant chemotherapy increases overall survival of patients with completely resected non-small cell lung cancer. Adjuvant therapy with immune checkpoint inhibitors and tyrosine kinase inhibitors have further improved outcome in selected patients. These therapeutic achievements are discussed in the present commentary.
No takes yet. Share an insight, caveat, or question.
Robert Pirker (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: